
==== Front
Curr Psychiatry Rep
Curr Psychiatry Rep
Current Psychiatry Reports
1523-3812
1535-1645
Springer US New York

39023732
1520
10.1007/s11920-024-01520-5
Correction
Correction to: Evidence‑Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders
Brand Bodyl A. b.a.brand@umcg.nl

Willemse Elske J. M.
Hamers Iris M. H.
Sommer Iris E.
grid.4494.d 0000 0000 9558 4598 Department of Biomedical Sciences and Systems, Cognitive Neurosciences, University of Groningen, University Medical Center Groningen (UMCG), Neuro Imaging Center 3111, Deusinglaan 2, Groningen, 9713 AW The Netherlands
18 7 2024
18 7 2024
2024
26 10 550551
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
issue-copyright-statement© Springer Science+Business Media, LLC, part of Springer Nature 2024
==== Body
pmcCorrection to: Current Psychiatry Reports (2023) 25:723–733.

10.1007/s11920-023-01460-6

The original version of this article unfortunately contained a mistake in the image of Fig. 1. Specifically, in section C. of this figure, the cut-off limit of prolactin is defined as 15 ng/L. The correct value of prolactin should be 25 ng/mL. The correct image is the following.

Fig. 1 Evidence-based recommendations for female-specific pharmacotherapy, based on three pillars: sex-specific dosing, hormonal replacement, and correction of prolactin levels. Abbreviations: AP, antipsychotic; PANSS, Positive and Negative Syndrome Scale; TDM, therapeutic drug monitoring; COC, combined oral contraceptive; HC, hormonal contraceptive; ARI, aripiprazole. Footnotes: 1Based on Schoretsanitis et al. [77•]. 2Based on the Stages of Reproductive Aging Workshop (STRAW + 10). 3Should be based on shared decision, primarily led by preference and/or current use of the participant. 4Amisulpride, asenapine, chlorpromazine, haloperidol, lurasidone, olanzapine, paliperidone, and risperidone

The original version of this paper has been corrected.

The online version of the original article can be found at 10.1007/s11920-023-01460-6.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
